Abstract:A complete biochemical understanding of the mechanisms by which hyperglycemia causes vascular functional and structural changes associated with the diabetic milieu still eludes us. In recent years, the numerous biochemical and metabolic pathways postulated to have a causal role in the pathogenesis of diabetic vascular disease have been distilled into several unifying hypotheses. These involve either increased reductive or oxidative stress to the cell, or the activation of numerous protein kinase pathways, part… Show more
“…First, the convincing in vitro demonstration of NO quenching by AGE may not be directly applicable in vivo [24]. Further studies indicate that AGEs can increase NO levels involving increased VEGF production [14,39].…”
These data demonstrate that AGEs formed from the nonenzymatic glycation of proteins with reducing sugars quench NO activities in vitro. The results implicate AGEs as important modulators of NO activity and may be relevant to the impairment of endothelial functions observed in diabetes and aging.
“…First, the convincing in vitro demonstration of NO quenching by AGE may not be directly applicable in vivo [24]. Further studies indicate that AGEs can increase NO levels involving increased VEGF production [14,39].…”
These data demonstrate that AGEs formed from the nonenzymatic glycation of proteins with reducing sugars quench NO activities in vitro. The results implicate AGEs as important modulators of NO activity and may be relevant to the impairment of endothelial functions observed in diabetes and aging.
“…We suggest that there was a causal association between VEGF up-regulation and hyperglycemia in the cochleae of diabetic rats. Many factors influence VEGF expression, including advanced glycation end products (AGEs), high glucose, and oxidative stress [6]. Hyperglycemia could induce the production of AGEs generated by non-enzymatic reactions between glucose and free amino reactive groups of proteins and lipids, and generation of reactive oxygen species (ROS).…”
Section: Discussionmentioning
confidence: 99%
“…Increased expression of VEGF has been implicated in a variety of disease conditions, including diabetic microvascular disease. Hyperglycemia can directly or indirectly induce VEGF expression [6], which has been considered in the pathogenesis of both diabetic nephropathy and retinopathy. The presence of VEGF and its receptors has been described in the cochlea of different rodents, which possibly regulate vascular permeability and endothelial proliferation in the inner ear [7].…”
Increased cochlear expression of VEGF, iNOS, and eNOS was detected in the diabetic rat. Furthermore, increased permeability of BLB was evidenced by increased cochlear EB extravasation in the diabetic rat.
“…Moreover, diabetic macular edema includes not only local edema caused by plasma components leaked from paramacular microaneurysms, but also diffuse edema caused by the breakdown of the blood-retinal barrier [5] and increased paramacular vascular permeability associated with retinal ischemia [6]. Vascular endothelial growth factor (VEGF) and various inflammatory cytokines are thus considered to be involved in increased vascular permeability [7,8].…”
In addition to inflammatory cytokines and neurotrophic factors such as VEGF, anti-inflammatory cytokines such as IL-10 and IL-13 may be involved more in the pathogenesis of DR and CRVO than in other diseases; cytokines and chemokines may also be correlated to VEGF in the vitreous fluid. It is also suggested that the inflammatory reaction may be more activate in CRVO than in DR.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.